ArticleFrontiers in oncology2025
Association between disseminated cancer and postoperative 30-day mortality in adult patients with brain tumor craniotomy.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Quantitative evidence on the association between disseminated cancer (DC) and 30-day postoperative mortality after tumor resection craniotomy in adults is limited. This study evaluates the association between them. Materials and methods: This retrospective analysis utilized propensity score matching (PSM) on cases extracted from the American College of Surgeons National Surgical Quality Improvement Program database (2012-2015). The study examined DC as the independent variable and 30-day postoperative mortality as the dependent outcome. A logistic regression analysis was conducted on the PSM data that were 1:1 matched. The DC-mortality association was assessed using robust statistical estimation methods. Results: The study cohort comprised 18,642 eligible patients (52.6% male, 47.4% female), including 4,022 (21.57%) with DC. The mortality rate was significantly higher in DC patients (4.97%) compared to the overall cohort undergoing tumor-related craniotomy (2.46%). Multivariate analysis and propensity score-adjusted analysis demonstrated that, compared with non-DC, the postoperative 30-day mortality of patients with DC undergoing craniotomy for brain tumors significantly increased, with associated odds ratios of 1.72 to 2.06. Conclusion: Given the relatively high risk of mortality within 30 days after craniotomy in patients with DC, both preoperative surgical decision-making and postoperative management strategies should be appropriately modified to reduce mortality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.